Skip to main content
Premium Trial:

Request an Annual Quote

Celera Genomics Reports Dwindling Revenues, Narrowed Loss for Q3 of FY2004

NEW YORK, April 27 (GenomeWeb News) - Celera Genomics' revenues fell sharply while its losses narrowed during the fiscal year 2004 third quarter, the company said today.


Revenues for the quarter decreased to $11.2 million, from $20.3 million during the same quarter last year. Celera attributed most of this decrease to expiring customer agreements.


Celera's R&D spending was $28.3 million, up from $27 million during the year-ago period.


The company's net loss for the quarter narrowed to $21.9 million, or $.3 per share, from $26.7 million, or $.37 per share, during the same period last year.


As of March 31, Celera Genomics, a unit of Applera, had $739 million in cash and short-term investments.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.